Intercept Pharmaceuticals to Conduct One-on-One Meetings with Investors at the Barclays Global Healthcare Conference March 14, 2023

Rhea-AI Summary

Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) announced its participation in the Barclays Global Healthcare Conference on March 14, 2023, at the Loews Miami Beach Hotel. This conference provides an opportunity for investors to engage with the Intercept management team, enhancing its visibility in the healthcare sector. Intercept focuses on innovative therapeutics for progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). The company encourages interested investors to connect for potential meetings with its management team.

Positive

• Participation in the Barclays Global Healthcare Conference may attract investor interest.
• Opportunity for management to engage directly with potential investors.

Negative

• None.

MORRISTOWN, N.J., March 09, 2023 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that it will be participating in investor meetings at the Barclays Global Healthcare Conference at the Loews Miami Beach Hotel on March 14, 2023. 

Meeting Details 
For investors attending the conference who wish to meet with the Intercept management team, please reach out to Nareg Sagherian at Intercept to check the team’s availability. 

About Intercept 
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH) and severe alcohol-associated hepatitis (sAH). For more information, please visit www.interceptpharma.com or connect with the Company on Twitter and LinkedIn.  

Contact 
For more information about Intercept, please contact: 

Investor inquiries: investors@interceptpharma.com 
Media inquiries: media@interceptpharma.com 

FAQ

When is Intercept Pharmaceuticals participating in the Barclays Global Healthcare Conference?

Intercept Pharmaceuticals will participate in the Barclays Global Healthcare Conference on March 14, 2023.

What is the focus of Intercept Pharmaceuticals?

Intercept Pharmaceuticals focuses on developing therapeutics for progressive non-viral liver diseases, including PBC and NASH.

Where is the Barclays Global Healthcare Conference being held?

The Barclays Global Healthcare Conference is being held at the Loews Miami Beach Hotel.

How can investors meet with Intercept management at the conference?

Investors interested in meeting with Intercept management should contact Nareg Sagherian to check availability.